Captor Therapeutics is a pharmaceutical firm specializing in the advancement of protein degradation medications for the treatment of cancer and autoimmune disorders, for which there are limited or no existing therapeutic options. Targeted Protein Degradation (TPD) addresses the therapeutic constraints of small molecules by overcoming drug resistance and separating their pharmacokinetics from pharmacodynamics. The innovative TPD technology facilitates the degradation of virtually any intracellular protein, including those considered 'undruggable'.
Captor Therapeutics
Headquarters
Poland